Business Context and Reporting Period
This Form 6-K filing by Zhengye Biotechnology Holding Limited reports the results of its Annual General Meeting of Shareholders held on March 24, 2026. The meeting took place at the company's principal executive offices in Jilin City, China, with virtual participation available. As of the record date on February 12, 2026, there were 47,391,376 ordinary shares outstanding.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance actions and shareholder voting results rather than financial performance data.
Material Changes and Corporate Actions
Shareholders represented 43,133,362 votes, constituting a quorum. The following resolutions were adopted:
- Election of two new director candidates.
- Re-election of certain current directors.
- Approval of share reclassification.
- Approval of share consolidation.
- Adoption of a new memorandum and articles of association.
Voting Results Summary
| Resolution | For | Against | Abstain |
|---|---|---|---|
| 1. Election of Directors | 43,092,532 | 24,730 | 16,100 |
| 2. Re-election of Directors | 43,090,399 | 26,743 | 16,220 |
| 3. Share Reclassification | 43,023,158 | 90,024 | 20,180 |
| 4. Share Consolidation | 43,088,491 | 44,771 | 100 |
| 5. New Articles of Association | 43,025,957 | 91,275 | 16,130 |
Guidance, Outlook, and Risks
The filing text does not provide a clear value for future guidance, management commentary on financial outlook, specific risks, or contingencies. The document is limited to the procedural outcomes of the shareholder meeting.
Investor Verification Checklist
- Verify the specific terms and effective date of the approved share reclassification and consolidation.
- Confirm the identities of the newly elected directors and the re-elected current directors.
- Review the full text of the new memorandum and articles of association to understand changes to corporate governance.
- Check subsequent filings for financial results, as this 6-K contains no financial data.